NewAmsterdam Pharma Co NV

NEW
NAS:NAMS (Netherlands)  
$ 17.97 -0.97 (-5.11%) 12:09 AM EST
At Loss
P/B:
4.19
Volume:
190.16K
Avg Vol (2M):
228.12K
Trade In:
Volume:
190.16K
At Loss
Avg Vol (2M):
228.12K

Business Description

Description
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
Name Current Vs Industry Vs History
Cash-To-Debt 766.38
Equity-to-Asset 0.87
Debt-to-EBITDA -0.01
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 15.74
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 23.69
9-Day RSI 39.4
14-Day RSI 47.51
6-1 Month Momentum % -23.89
12-1 Month Momentum % 131.52

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.83
Quick Ratio 9.83
Cash Ratio 9.51

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.4
Shareholder Yield % -11.17

Financials

NAMS's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NAMS

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

NewAmsterdam Pharma Co NV Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 3.68
EPS (TTM) ($) -2.62
Beta 0
Volatility % 88.37
14-Day RSI 47.51
14-Day ATR ($) 0.808398
20-Day SMA ($) 18.5735
12-1 Month Momentum % 131.52
52-Week Range ($) 8.64 - 26.35
Shares Outstanding (Mil) 90.02

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

NewAmsterdam Pharma Co NV Filings

Filing Date Document Date Form
No Filing Data

NewAmsterdam Pharma Co NV Stock Events

Financials Calendars
Event Date Price($)
No Event Data

NewAmsterdam Pharma Co NV Frequently Asked Questions

What is NewAmsterdam Pharma Co NV(NAMS)'s stock price today?
The current price of NAMS is $17.97. The 52 week high of NAMS is $26.35 and 52 week low is $8.64.
When is next earnings date of NewAmsterdam Pharma Co NV(NAMS)?
The next earnings date of NewAmsterdam Pharma Co NV(NAMS) is .
Does NewAmsterdam Pharma Co NV(NAMS) pay dividends? If so, how much?
NewAmsterdam Pharma Co NV(NAMS) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1